|
Asian-Oceanian Journal of Pediatrics and Child Health
Volume Three December 2004 Number Two
PATHOGENESIS OF DENGUE SHOCK SYNDROME: IMMUNE ENHANCEMENT OR VIRAL
VIRULENCE
Olarn Prommalikit, M.D.1,
Chitsanu Pancharoen, M.D.2
Ananda Nisalak, M.D.3
Usa Thisyakorn M.D.2
Chule Thisyakorn, M.D.2
-
Department of Pediatrics, Faculty of Medicine, Srinakharinwirot
University, Nakorn-nayok, Thailand
-
Department of Pediatrics, Faculty of Medicine, Chulalongkorn
University, Bangkok, Thailand
-
Armed Forces Research Institute of Medical Sciences (AFRIMS),
Bangkok, Thailand
Corresponding Author:
OLARN
PROMMALIKIT, M.D. Infectious Diseases Unit, Department of Pediatrics,
Faculty of Medicine, Srinakharinwirot University Rungsit-Ongkarax Road, Ongkarax,
Nakorn-nayok 26120, Thailand Tel. (66-37) 395085-8 ext 10901 Fax. (66-37) 395275 E-mail: drolarnp2002@yahoo.com
ABSTRACT
Background:
The pathogenesis of dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS) is not clearly understood. Two hypotheses i.e. immune
enhancement and viral virulence have been debated.
Objective:
To study the correlation between dengue serotypes,
serologic responses, and disease severity.
Materials & Methods:
We enrolled children who were clinically
and serologically diagnosed as dengue virus infection and were
admitted to King Chulalongkorn Memorial Hospital, Bangkok, Thailand,
during a period of one year. They were clinically classified as
non-shock (dengue fever, DHF grade I & II) and shock (DHF grade III
& IV), and were serologically classified as primary and secondary infections.
Viral isolation was done and serotypes of dengue virus were
identified. Chi-square test and analysis of variance were used for
statistical analysis.
Results:
Dengue virus was isolated from 120 out of 555
children (21.6%). Of these, 73 (60.8%) were classified into
non-shock group and 47 (39.2%) were classified into shock group.
Primary and secondary dengue infections were found in 26 (21.7%) and
94 (78.7%) respectively. Patients with secondary infection developed
shock more often than those with primary infection (47.9% vs 7.7%, p
< 0.05). Common serotypes of dengue virus (DEN) isolated were DEN-2
(30.8%) and DEN-3 (60.8%). Patients infected with DEN-2 developed
shock more often than those infected with DEN-3 and DEN-1, (56.8% vs
32.9% vs 20.0%, p < 0.05). After using logistic regression analysis,
serologic response was the only risk factor for the disease
severity.
Conclusions:
This study supported that immune enhancement
plays an important role in pathogenesis of DSS.
Key words: Dengue virus, Immune enhancement, Viral Virulence,
Shock, DSS.
|
Information |